Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Ganglioside GM1 Ab:PrThr:Pt:Ser:Ord:IF

Known as: Ganglioside GM1 Antibody:Presence or Threshold:Point in time:Serum:Ordinal:Immune Fluorescence, Ganglioside GM1 , Ac:Présence-Seuil:Temps ponctuel:Sérum:Ordinal:Immunofluorescence, S--monosialoganglioside GM1, Ig; ; IF 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Background: Medin is a 50 amino acid peptide that forms amyloid deposits in the vasculature. It is the most common human amyloid… Expand
Is this relevant?
2013
2013
An approach based on liquid chromatography-tandem mass spectrometry was developed for the quantification of monosialogangliosides… Expand
Is this relevant?
2008
2008
Aim :To study the protective effect of monosialoganglioside-GM1 on people inflicted of severe traumatic brain injury(STBI… Expand
Is this relevant?
2007
Highly Cited
2003
Highly Cited
2003
The conversion of soluble, nontoxic amyloid beta-protein (A beta) to aggregated, toxic A beta rich in beta-sheet structures is… Expand
Is this relevant?
2003
2003
BACKGROUND Tay-Sachs disease is a form of monosialoganglioside triaose (GM2) gangliosidosis that results from the mutations in… Expand
Is this relevant?
1994
1994
Background and Purpose The Early Stroke Trial (EST) is a randomized, double-blind, placebo-controlled trial to assess the effect… Expand
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
1990
1990
We describe the immunomodulatory activity of GM-1/P a processed form of GM-1 (monosialoganglioside) extracted from ox brain… Expand
Is this relevant?
1990
1990
Reported here are the results of an open controlled study on the use of GM1 in cases of ischemic strokes in its acute phase. A… Expand
Is this relevant?